Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
USI Awarded S&P Global Bronze Class in Sustainability Yearbook 2022 2022-02-10 07:00
NSF International's President and Chief Executive Officer (CEO) Kevan Lawlor Announces Retirement; Pedro Sancha to Succeed Lawlor as President and CEO 2022-02-09 23:00
Correction: Year-end report 2021 Bactiguard Holding AB 2022-02-09 22:17
X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets 2022-02-09 22:00
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration 2022-02-09 21:30
Angel Yeast's Patented Probiotic S. boulardii Alleviates Common IBD Symptoms, New Research Shows 2022-02-09 21:00
Mobile Medical Imaging Systems Improving Care Accessibility and Convenience for Patients 2022-02-09 20:00
Best-in-class companies in Asia-Pacific Recognized by the Frost & Sullivan Best Practices 2022-02-09 19:17
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors 2022-02-09 17:10
Hummingbird Bioscience Publishes Preclinical Data Demonstrating Therapeutic Potential of HMBD-002 in VISTA-expressing Cancers 2022-02-09 17:00
Glenmark and SaNOtize announce positive Results from Phase 3 Clinical Trial of NONS (FabiSpray®) in Non-Hospitalized Adult Indian Patients with COVID-19 2022-02-09 15:47
China Life Singapore Aims to Expand Agency Channel to 100 Agents with Enhanced New Business Model 2022-02-09 12:52
COLOPLAST SINGAPORE LAUNCHES SENSURA MIO(R), A PRODUCT MADE WITH THE LATEST TECHNOLOGY FOR OSTOMY AND STOMA CARE 2022-02-09 12:44
Luye Pharma Grants Laboratorio LIBRA Exclusive Marketing Rights for Seroquel and Seroquel XR in Chile 2022-02-09 11:57
CStone announced new drug approval of China's first IDH1 inhibitor TIBSOVO® (ivosidenib tablets) as a new precision therapy for patients with acute myeloid leukemia 2022-02-09 11:53
Bugworks Research Inc. secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock India 2022-02-09 10:00
Bactiguard presents focused growth strategy and sets new long-term financial targets 2022-02-09 07:27
First Proton Therapy Treatment Delivered in Southeast Asia at Her Royal Highness Princess Maha Chakri Sirindhorn Proton Center, Thailand 2022-02-09 05:15
Bactiguard and Zimmer Biomet expand global license partnership 2022-02-09 04:10
Cambrex Recognized with 2022 CMO Leadership Awards for the 8th Consecutive Year 2022-02-08 22:30
1 233 234 235 236 237 739